Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • drabe
    Junior Member
    • Dec 2008
    • 1

    #1

    Enrichement and Picogreen concentrations?

    Hello,
    I am trying to do a ChIP for ChIP-Seq for a transcription factor (TF) that has no known binding site so far. I therefore can't check my enrichment by qPCR, and the only ways to QC my ChIP are western-blot and Picogreen qtification.
    My western looks ok, but my Picogreen assays show not difference of DNA concentration between the control and my TF sample. Is it normal or should I see a difference. Is it a bad sign for the future ChIP-Seq experiment (too much background)?
    I don't know what the fraction of my specifically enriched DNA should be: 1 or 50% of the amount of background DNA.
    Anyone can help?
    Thanks a lot!
  • cjohns
    Junior Member
    • Sep 2008
    • 7

    #2
    Our picogreen concentrations of our ChIP and our Normal Rabbit IgG control can have very similar concentrations after sample prep. In our experience, the only way to know if a specific antibody worked (even if checked on western and pcr) is to sequence it and look at the differences. At that point the bad sign is if the peaks are at the same place when mapped to the genome.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM
    • SEQadmin2
      New Genomics Technologies Take Aim at Long-Standing Limits
      by SEQadmin2


      Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

      We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
      ...
      09-28-2026, 10:25 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, Yesterday, 11:13 AM
    0 responses
    14 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, Yesterday, 10:48 AM
    0 responses
    13 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-15-2026, 10:52 AM
    0 responses
    35 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-14-2026, 05:39 AM
    0 responses
    42 views
    0 reactions
    Last Post SEQadmin2  
    Working...